Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Drug-Induced Liver Injury and CYP2C9[original query] |
---|
Association of CYP2C9*2 with bosentan-induced liver injury. Clinical pharmacology and therapeutics 2013 Dec 94 (6): 678-86. Markova S M, De Marco T, Bendjilali N, Kobashigawa E A, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie A E, Khojasteh C, McGlothlin D, Wu A H B, Hsueh W-C, Witte J S, Schwartz J B, Kroetz D |
Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population. Clinical and experimental pharmacology & physiology 2013 May 40 (5): 326-32. Tang Shao-Wen, Lv Xiao-Zhen, Chen Ru, Wu Shan-Shan, Yang Zhi-Rong, Chen Da-Fang, Zhan Si-Y |
[Predictive genomic markers for severe adverse drug reactions]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2015 135 (4): 589-95. Saito Yoshiro, Kodama Susumu, Sugiyama Emiko, Nakamura Ryosu |
[POLYMORPHISM OF CYP2C9 GENE AND RISK OF HEPATOTOXICITY DEVELOPMENT DURING ANTIRETROVIRAL THERAPY.] Eksperimental'naia i klinicheskaia farmakologiia 2016 79 (9): 18-21. Kurbat M N, Tsyrkunov V M, Stepuro T |
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag: a case report. Journal of medical case reports 2022 10 16 (1): 385. Lattanzio Mariangela, Ferrari Marco, Martini Stefano, Ceriani Francesca, Imporzani Andrea, Marino Franca, De Ponti Roberto, Cosentino Mar |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: